X-Linked Retinitis Pigmentosa Clinical Trials

20 clinical trials for X-Linked Retinitis Pigmentosa across international registries, including 3 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• InsightRP2 Registry — RECRUITING
• A Study Comparing Two Doses of AGTC-501 in Male Participants With X-linked Retinitis Pigmentosa Caused by RPGR Mutations (DAWN) — RECRUITING · PHASE2
• Gene Therapy for Subjects With RPGR Mutation-associated X-linked Retinitis Pigmentosa — RECRUITING · PHASE1
• A Follow-on Study for Second-Eye Treatment for Participants Previously Treated With Gene Therapy for X-Linked Retinitis Pigmentosa (XLRP) — ACTIVE_NOT_RECRUITING · PHASE2
• Follow-up Gene Therapy Trial for the Treatment of X-linked Retinitis Pigmentosa Associated With Variants in the RPGR Gene — ACTIVE_NOT_RECRUITING · PHASE3
• Long-term Safety and Efficacy Follow-up of BIIB111 for the Treatment of Choroideremia and BIIB112 for the Treatment of X-Linked Retinitis Pigmentosa — COMPLETED · PHASE3
• A Phase 2 Open-label Study to Evaluate the Safety of Laruparetigene Zovaparvovec Administered Bilaterally in Male Participants With X-Linked Retinitis Pigmentosa — ACTIVE_NOT_RECRUITING · PHASE2
• A Clinical Trial Evaluating the Safety and Efficacy of a Single Subretinal Injection of AGTC-501 in Participants With XLRP — ACTIVE_NOT_RECRUITING · PHASE2
• Gene Therapy Trial for the Treatment of X-linked Retinitis Pigmentosa Associated With Variants in the RPGR Gene — COMPLETED · PHASE3
• Long-term Follow-up Gene Therapy Study for RPGR- XLRP — COMPLETED
• An Observational Study of Japanese Participants With X-linked Retinitis Pigmentosa — COMPLETED
• 4D-125 in Patients With X-Linked Retinitis Pigmentosa (XLRP) — ACTIVE_NOT_RECRUITING · PHASE1
• Gene Therapy for X-linked Retinitis Pigmentosa (XLRP) - Retinitis Pigmentosa GTPase Regulator (RPGR) — COMPLETED · PHASE1
• A Randomized, Controlled, Masked, Multi-center Study Evaluating the Efficacy, Safety, and Tolerability of Two Doses of AGTC-501 Compared to an Untreated Control Group in Male Participants with X-linked Retinitis Pigmentosa — OTHER · PHASE3
• A Study Comparing Two Doses of AGTC-501 in Male Subjects With X-linked Retinitis Pigmentosa Caused by RPGR Mutations (SKYLINE) — ACTIVE_NOT_RECRUITING · PHASE2
• Gene Therapy for RPGR Gene Mutation-associated X-linked Retinitis Pigmentosa — OTHER · PHASE1
• Safety and Efficacy of rAAV2tYF-GRK1-RPGR in Subjects With X-linked Retinitis Pigmentosa Caused by RPGR Mutations — ACTIVE_NOT_RECRUITING · PHASE1
• A Clinical Trial of Retinal Gene Therapy for X-linked Retinitis Pigmentosa Using BIIB112 — COMPLETED · PHASE1
• Natural History of the Progression of X-Linked Retinitis Pigmentosa — COMPLETED
• Clinical Evaluation of Patients With X-linked Retinitis Pigmentosa (XLRP) — COMPLETED

Refine this search